Please login to the form below

Alfred Sandrock

This page shows the latest Alfred Sandrock news and features for those working in and with pharma, biotech and healthcare.

of our findings,” said Alfred Sandrock head of research and development at Biogen.

Biogen and Ionis post ‘encouraging’ early results for Alzheimer’s disease candidate

Biogen is encouraged by the results of this trial, and we look forward to our continued research in future clinical studies with this promising investigational asset,” said Alfred Sandrock, head of
Biogen pays InnoCare $125m upfront for potential multiple sclerosis treatment

programs,” said Alfred Sandrock, Jr., head of research and development at Biogen.
FDA narrows label for Biogen’s Aduhelm to only include mild forms of Alzheimer’s disease

We are committed to continue to listen to the community’s needs as clinical practice adapts to this important, first-in-class treatment option,” said Alfred Sandrock, head of research and
Biogen discontinues clinical development of anti-tau antibody for Alzheimer’s disease

from each trial,” said Alfred Sandrock, head of research and development at Biogen.
Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Together with our collaboration partners at Sage, we are proud to announce highly encouraging results from the phase 3 WATERFALL Study of zuranolone in major depressive disorder,” said Alfred Sandrock, Jr.,

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Biogen's Douglas Williams departs for biotech start-up

Williams will be replaced by chief medical officer Alfred Sandrock and chief scientific officer Spyros Artavanis-Tsakonas, who will be handed joint responsibility for Biogen Research and Development. ... We are fortunate to have Al Sandrock and Spyros
Biogen Idec names VP for value-based medicine

Through his years of hands-on clinical experience, he has gained a truly unique understanding of the needs of MS patients,” said Alfred Sandrock, chief medical officer of Biogen Idec.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Exciting Medical Writer Career Opportunity for Postdoc, Medcomms: Highly competitive salary

Add my company

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Virtual Steering Committee & Peer Influence Program: In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges: The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement: How does Pharma-HCP engagement need to evolve in today's digital landscape?...

Email:
Password: